The Cleveland Clinic

820 clinical trials · Sponsor

Record	Firm	Date
Endovascular Exclusion of TAAA/AAA Utilizing Fenestrated/Branched Stent Grafts (NCT00583050)	The Cleveland Clinic	2001-02-01
Interferon Alfa in Treating Patients With Stage IV Solid Tumors, Lymphoma, or Myeloma (NCT00276536)	The Cleveland Clinic	2001-01-01
Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients (NCT00137748)	The Cleveland Clinic	2001-01-01
GeneBank at the Cleveland Clinic: Molecular Determinants of Coronary Artery Disease (NCT00590200)	The Cleveland Clinic	2001-01-01
The Effect of Lipitor on Aortic Stenosis (NCT00590135)	The Cleveland Clinic	2000-08-01
VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL (NCT00274794)	The Cleveland Clinic	2000-02-01
Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) (NCT00289042)	The Cleveland Clinic	1999-12-01
Combination Chemotherapy in Treating Patients With Multiple Myeloma (NCT00003493)	The Cleveland Clinic	1998-11-01
Nitrous Oxide and Risk of Cancer Recurrence After Colorectal Surgery: A Randomized, Blinded Study (NCT00781352)	The Cleveland Clinic	1998-11-01
Rituximab in Treating Patients With Multiple Myeloma (NCT00003554)	The Cleveland Clinic	1998-11-01
Combination Chemotherapy Following GM-CSF in Treating Patients With Multiple Myeloma (NCT00003490)	The Cleveland Clinic	1998-10-01
Endovascular Exclusion of Abdominal Aortic Aneurysms in High Risk Patients (NCT00583414)	The Cleveland Clinic	1998-09-01
Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced Cancer (NCT00004036)	The Cleveland Clinic	1997-11-01
Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome (NCT01373333)	The Cleveland Clinic	1997-09-01
Biological Therapy in Treating Patients With Glioblastoma Multiforme (NCT00003185)	The Cleveland Clinic	1997-08-01
Phase II Randomized Study of Glucocorticoids With or Without Methotrexate for Treatment of Giant Cell Arteritis (NCT00004686)	The Cleveland Clinic	1994-02-01
ABRIDGE: Low Molecular Weight Heparin in Bridging Patients After Mechanical Valve Replacement (NCT00298285)	The Cleveland Clinic
A Phase I - II Safety Study of Filgrastim (Neupogen) to Improve Left Ventricular Function After Severe Acute Myocardial Infarction (NCT00215124)	The Cleveland Clinic
Outcomes of Partial Versus Complete Tonsillectomy for Obstructive Sleep Disordered Breathing (NCT00519402)	The Cleveland Clinic
Arsenic Trioxide, Ascorbic Acid, Dexamethasone, and Thalidomide in Treating Patients With Multiple Myeloma (NCT00112879)	The Cleveland Clinic

Track The Cleveland Clinic automatically

Every clearance here is in the API, with alerts when new ones post.